Sun Care Sponsored by
An Australian scientist who developed a vaccine for cervical cancer is set to outline a breakthrough which could pave the way for a skin cancer vaccine.
Professor Ian Frazer told The Sunday Telegraph that tests of the vaccine on animals had proven successful and that human trials could begin as soon as next year. "If we can get encouraging results, we will try and push it on as fast as we can," he told the paper.
Frazer also said a skin cancer vaccine could be available in five to 10 years. It would be used on children aged between 10 and 12 to prevent them from developing skin cancer, a disease which causes some 1,600 deaths in Australia each year. The new vaccine would target papillomavirus, a common infection which can turn abnormal cells into cancer.
Frazer, a University of Queensland researcher who developed the cervical cancer vaccine Gardasil, said it was not yet known how many skin cancers were caused by the virus. "My entire career has been focused on understanding the interaction between papillomavirus and the cancers," he said. "We know it causes at least 5% of all cancers globally."
Close to 400,000 people are diagnosed with skin cancer in the sunburnt country each year, and Frazer said that even if the vaccine worked on humans, people should not stop protecting themselves from the sun. "A vaccine is not a replacement for prevention," he noted.